amiloride has been researched along with Peritoneal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glavic, Z; Hrgovic, I; Hrgovic, Z; Kovacic, Z; Mulic, S; Zunic, L | 1 |
Chen, Q; Ding, Y; Wang, X; Zhang, H; Zhong, M; Zhou, Z; Zhu, Z | 1 |
Baba, M; Iishi, H; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H | 1 |
3 other study(ies) available for amiloride and Peritoneal Neoplasms
Article | Year |
---|---|
Repeated administration of inhibitors for ion pumps reduce markedly tumor growth in vivo.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Cell Division; Cell Proliferation; Hydrogen-Ion Concentration; Ion Pumps; Mastocytoma; Mice; Mice, Inbred DBA; Peritoneal Neoplasms; Tumor Burden; Tumor Microenvironment | 2014 |
u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.
Topics: Acid Sensing Ion Channel Blockers; Amiloride; Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2012 |
Suppression by amiloride of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane.
Topics: Adenocarcinoma; Amiloride; Animals; Anticarcinogenic Agents; Azoxymethane; Bombesin; Drug Interactions; Intestinal Neoplasms; Male; Peritoneal Neoplasms; Rats; Rats, Wistar | 1995 |